-
公开(公告)号:US10718022B2
公开(公告)日:2020-07-21
申请号:US15566533
申请日:2016-04-15
Applicant: University of Massachusetts
Inventor: Michael R. Green , Sanchita Bhatnagar
IPC: C12Q1/6883 , G01N33/50
Abstract: In some aspects, the disclosure relates to the reactivation of inactive X chromosomes (Xi). In some embodiments, the disclosure provides compositions and methods for the reactivation of inactive X chromosomes. In some embodiments, the compositions and methods described by the disclosure may be useful for the treatment of dominant X-linked diseases.
-
公开(公告)号:US10130679B2
公开(公告)日:2018-11-20
申请号:US15074714
申请日:2016-03-18
Applicant: University of Massachusetts
Inventor: Michael R. Green , Guangping Gao , Manas Kumar Santra , Sanchita Bhatnagar
Abstract: Methods of treating a tumor in a subject include identifying a subject having, at risk for, or suspected of having a tumor, and administering to the subject an effective amount of an SRPX.
-
公开(公告)号:US20250115593A1
公开(公告)日:2025-04-10
申请号:US18904487
申请日:2024-10-02
Applicant: TRUSTEES OF BOSTON UNIVERSITY , University of Massachusetts
Inventor: John A. PORCO, Jr. , Zihao WANG , Lauren E. BROWN , Stanley I. Goldstein , Sunll K. MALONIA , Ritesh P. THAKARE , Alok K. MISHRA , Michael R. Green
IPC: C07D413/12 , A61K31/343 , A61K31/397 , A61K31/4025 , A61K31/4184 , A61K31/4525 , A61K31/5377 , A61P35/00 , C07D307/93 , C07D405/04 , C07D405/10 , C07D405/12
Abstract: The disclosure provides rocaglate acyl sulfamides (Roc ASFs), compositions and kits comprising same, and methods for their use.
-
公开(公告)号:US11963975B2
公开(公告)日:2024-04-23
申请号:US17489983
申请日:2021-09-30
Applicant: University of Massachusetts
Inventor: Peter L. Jones , Michael R. Green
IPC: C12N15/113 , A61K31/5513 , A61K31/7105 , A61K31/713 , A61K45/06 , C12N15/90 , G01N33/50
CPC classification number: A61K31/7105 , A61K31/5513 , A61K31/713 , A61K45/06 , C12N15/113 , C12N15/90 , G01N33/5061 , C12N2310/11 , C12N2310/14 , C12N2310/20 , C12N2740/16043
Abstract: The disclosure relates to methods and compositions for regulating expression of DUX4. In some aspects, methods described by the disclosure are useful for treating a disease associated with aberrant DUX4 expression (e.g., facioscapulohumeral muscular dystrophy).
-
公开(公告)号:US20200276266A1
公开(公告)日:2020-09-03
申请号:US16815356
申请日:2020-03-11
Applicant: University of Massachusetts
Inventor: Michael R. Green , Guangping Gao , Manas Kumar Santra , Sanchita Bhatnagar
Abstract: Methods of treating a tumor in a subject include identifying a subject having, at risk for, or suspected of having a tumor, and administering to the subject an effective amount of an SRPX.
-
公开(公告)号:US20180256749A1
公开(公告)日:2018-09-13
申请号:US15760765
申请日:2016-09-16
Applicant: University of Massachusetts
Inventor: Michael R. Green , Minggang Fang , Walter Kowtoniuk
IPC: A61K48/00 , A61K31/496 , A61K31/713 , A61K31/549 , A61K31/706 , A61K31/5377 , A61K39/395 , A61K38/45 , A61K38/53 , A61K31/711 , A61K31/7105 , A61K35/30 , C12N15/113 , C12Q1/6883 , A61P25/14 , A61P15/02
CPC classification number: A61K48/005 , A61K31/167 , A61K31/404 , A61K31/437 , A61K31/4406 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/522 , A61K31/5377 , A61K31/546 , A61K31/549 , A61K31/706 , A61K31/7088 , A61K31/7105 , A61K31/711 , A61K31/713 , A61K35/30 , A61K38/45 , A61K38/53 , A61K39/3955 , A61K48/0016 , A61P15/02 , A61P25/14 , C12N15/113 , C12N2310/11 , C12N2310/14 , C12N2310/141 , C12N2310/531 , C12Q1/6883 , C12Q2600/154 , C12Q2600/158 , C12Y201/01037 , C12Y201/01043 , C12Y603/02019
Abstract: The disclosure relates to methods and compositions for reactivating a silenced FMR1 gene. In some aspects, methods described by the disclosure are useful for treating a FMR1-inactivation-associated disorder (e.g., fragile X syndrome).
-
公开(公告)号:US20180087110A1
公开(公告)日:2018-03-29
申请号:US15566533
申请日:2016-04-15
Applicant: University of Massachusetts
Inventor: Michael R. Green , Sanchita Bhatnagar
IPC: C12Q1/6883 , G01N33/50
Abstract: In some aspects, the disclosure relates to the reactivation of inactive X chromosomes (Xi). In some embodiments, the disclosure provides compositions and methods for the reactivation of inactive X chromosomes. In some embodiments, the compositions and methods described by the disclosure may be useful for the treatment of dominant X-linked diseases.
-
公开(公告)号:US20170183741A1
公开(公告)日:2017-06-29
申请号:US15308673
申请日:2015-05-14
Applicant: University of Massachusetts
Inventor: Michael R. Green , Leyuan Ma
IPC: C12Q1/68 , A61K31/506 , A61K31/519 , G01N33/574
CPC classification number: C12Q1/6886 , A61K31/506 , A61K31/519 , C12Q2600/106 , C12Q2600/156 , C12Q2600/158 , G01N33/57426 , G01N2333/91205 , G01N2800/52
Abstract: Methods for treating chronic myeloid leukemia (CML), e.g., BCR-ABL inhibitor imatinib mesylate (IM)-resistant CML, using combination treatments, e.g., combined treatment with a BCR-ABL inhibitor, e.g., IM, and a MEK inhibitor, e.g., trametinib.
-
公开(公告)号:US11819554B2
公开(公告)日:2023-11-21
申请号:US15760765
申请日:2016-09-16
Applicant: University of Massachusetts
Inventor: Michael R. Green , Minggang Fang , Walter Kowtoniuk
IPC: A61K31/711 , A61K35/30 , A61K38/45 , A61K38/53 , A61K39/395 , A61K48/00 , A61K31/5377 , A61K31/549 , A61K31/706 , A61K31/713 , C12Q1/6883 , C12N15/113 , A61K31/7088 , A61K31/404 , A61K31/546 , A61K31/167 , A61K31/497 , A61K31/506 , A61K31/437 , A61K31/4406 , A61K31/522 , A61K31/496 , A61P25/14 , A61P15/02 , A61K31/7105
CPC classification number: A61K48/005 , A61K31/167 , A61K31/404 , A61K31/437 , A61K31/4406 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/522 , A61K31/5377 , A61K31/546 , A61K31/549 , A61K31/706 , A61K31/7088 , A61K31/711 , A61K31/713 , A61K31/7105 , A61K35/30 , A61K38/45 , A61K38/53 , A61K39/3955 , A61K48/0016 , A61P15/02 , A61P25/14 , C12N15/113 , C12Q1/6883 , C12N2310/11 , C12N2310/14 , C12N2310/141 , C12N2310/531 , C12Q2600/154 , C12Q2600/158 , C12Y201/01037 , C12Y201/01043 , C12Y603/02019
Abstract: The disclosure relates to methods and compositions for reactivating a silenced FMR1 gene. In some aspects, methods described by the disclosure are useful for treating a FMR1-inactivation-associated disorder (e.g., fragile X syndrome).
-
公开(公告)号:US20220259654A1
公开(公告)日:2022-08-18
申请号:US17585765
申请日:2022-01-27
Applicant: University of Massachusetts
Inventor: Michael R. Green , Sanchita Bhatnagar
IPC: C12Q1/6883 , G01N33/50
Abstract: In some aspects, the disclosure relates to the reactivation of inactive X chromosomes (Xi). In some embodiments, the disclosure provides compositions and methods for the reactivation of inactive X chromosomes. In some embodiments, the compositions and methods described by the disclosure may be useful for the treatment of dominant X-linked diseases.
-
-
-
-
-
-
-
-
-